Presented
by

Presented by Oxford Global

Member Login
|
Become a Member

Next Up

Antibody Engineering: Online

27 - 29 June 2022 |

Online: BST (UTC+1)

27 - 29 June 2022

Online: BST (UTC+1)

A focused 3-day meeting that delves into emerging technologies in antibody-based molecular engineering, novel & difficult targets, antibody-based therapeutics & a meeting place for experts working within engineering, computational tools and biotherapeutics. 

> Visit Event Website

23 Jun 2022
Thu, 23 June 2022

Bactericidal Antibody Response: Measuring Immunogenicity and Vaccine Efficacy

Presented by Nexelis

> More Information

14 Sep 2022
Wed, 14 September 2022

Oligonucleotide Chemistry & Therapeutics Symposium

An intensive 1-day meeting that delves into the latest developments in oligonucleotide synthesis, chemistry, process & analytical development, and therapeutics

> Visit Event Website

10 Nov 2022
Thu, 10 November 2022

Upcoming Biologics Nexelis Webinar

Presented by Nexelis

> More Information

> See All Upcoming Oxford Global Biologics Events
> See All Webinars & Recordings

Highlights

Vaccines Europe
Industry Spotlight
Most Anticipated Presentations: Vaccines Europe
Discover key event highlights from Oxford Global's upcoming Vaccines Congress 2022.
Edited by Tia Byer |
24 June 2022
Vaccines
Discussion Group Report
Oral Delivery of Peptides
Edited by Tia Byer |
24 Jun 2022
Peptides
Industry Spotlight
Top 3 Biologics News Headlines
Edited by Tia Byer |
22 Jun 2022
Proteins & Antibodies

In-Depth

Oral Delivery of Peptides
Discussion Group Report
Oral Delivery of Peptides
Nazneen Dewji, President and CEO of Cenna Biosciences leads a discussion on the strategies to overcome the challenges ‘Oral Delivery of Peptides’.
24 June 2022
Cell Engager Redirection
Insight Article
Broadening Horizons for Bispecific Effector Cell Redirection
Key opinion leaders share their thoughts on the prospect of effector cell redirection and cell engagers at Biologics UK: In-Person 2022.
07 June 2022
Recombinant Peptide Production
Commentary
Peptide Production: Biopharmaceutical Manufacturing of Next Generation Peptides
In this Commentary article, we explore how innovative technologies like expression tags could help to overcome challenges associated with recombinant peptide production. The potential for recombinant production to slash manufacturing costs has made it a focal area of research for companies such as Boehringer Ingelheim.
17 May 2022
Peptide Disovery
Insight Article
Peptide Discovery: Unlocking the Future of Disruptive Therapeutics
UCB, Bicycle Therapeutics, and Sanofi share their latest findings in Peptide discovery at Biologics UK 2022.
10 May 2022
> See All In-Depth

Industry Spotlight

Vaccines Europe
Industry Spotlight
Most Anticipated Presentations: Vaccines Europe
Discover key event highlights from Oxford Global's upcoming Vaccines Congress 2022.
24 June 2022
Clinical Trials Headlines
Industry Spotlight
Top 3 Biologics News Headlines
Hot off the press, we look at this week’s breaking news stories from the Biologics industry.
22 June 2022
COVID Treatment Challenges
Industry Spotlight
Delays for New COVID Drugs
Clinical studies testing treatments for severe COVID-19 face major delays due to eligibility issues.
17 June 2022
MMR Vaccine
Industry Spotlight
FDA Approves GSK’s MMR Vaccine
The FDA gives the green light to GSK’s measles, mumps, and rubella vaccine, providing US clinicians with a new treatment option for childhood inoculation for first time in more than 50 years.
09 June 2022
> See All

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Twitter Linkedin-in

Event Series

About

Careers

Legal

Copyright Oxford Global Marketing Limited. All rights reserved.

Member Community Login